ASAPIPRANT
UNII B2LW71CRGL

Substance Identification & Data

This profile provides standardized clinical and technical data for Asapiprant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2LW71CRGL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 932372-01-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B2LW71CRGL

CAS Registry Number

932372-01-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ASAPIPRANT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C24H27N3O7S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ZMZNWNTZRWXTJU-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C171866

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

59232326

Unique identification number in the NCBI database of chemical substances.

INN ID

9781

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(COc1c(ccc(c1)N2CCN(CC2)S(=O)(=O)c3ccc(cc3)OC(C)C)-c4occn4)(=O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Asapiprant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.